Skip to main content
Premium Trial:

Request an Annual Quote

Advanced Cell Diagnostics RNAscope 2.5

Advanced Cell Diagnostics has launched RNAscope 2.5, a next-generation in situ hybridization assay for RNA biomarker analysis in FFPE tissue. The new assay incorporates many refinements and enhancements to enable rapid, accurate assessment of tissue-based biomarker expression across the full spectrum of FFPE clinical tissue samples at unprecedented levels of consistency and reproducibility without the need for lengthy rounds of assay optimization, said ACD in a statement. 

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more